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Sepsis is a major cause of mortality worldwide 
characterized by a dysregulated inflammatory re-
sponse to infection (Hotchkiss and Karl, 2003). 
Excessive inflammation accounts for serious 
complications, but unfortunately, strategies tar-
geting key proinflammatory mediators have   
had only very limited success (Fisher et al., 1996;   
Riedemann et al., 2003), demonstrating the 
complex pathogenesis of the disorder that is de-
termined by a variety of both pathogen and host 
factors. Notably, patients with chronic liver dis-
eases have significantly increased risk of acquiring 
sepsis and its accompanying complications, and 
thus have higher sepsis-related mortality, with it 
accounting  for  30%  of  all  deaths  in  cirrhotic   
patients (Foreman et al., 2003). The underlying 
mechanisms for this clinical observation are only 
partially understood.
The liver is the major source of acute-phase 
proteins (APPs), which are defined as proteins 
whose serum levels change by >25% during   
inflammation (Gabay and Kushner, 1999), and 
they are regarded as important components of the 
innate immune response to infection (Medzhitov, 
2007). Many APPs are known as potent opso-
nins (Shah et al., 2006) and activators of innate 
immune cells such as neutrophils (Cheng et al., 
2008a), but they also have antiinflammatory 
properties  (Zouki  et  al.,  1997).  Because  of   
the  large  diversity  of  APPs  with  both  pro-   
and  antiinflammatory  functions  (Gabay  and 
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Acute-phase proteins (APPs) are an evolutionarily conserved family of proteins produced 
mainly in the liver in response to infection and inflammation. Despite vast pro- and anti-
inflammatory properties ascribed to individual APPs, their collective function during 
infections remains poorly defined. Using a mouse model of polymicrobial sepsis, we show 
that abrogation of APP production by hepatocyte-specific gp130 deletion, the signaling 
receptor shared by IL-6 family cytokines, strongly increased mortality despite normal 
bacterial clearance. Hepatic gp130 signaling through STAT3 was required to control 
systemic inflammation. Notably, hepatic gp130–STAT3 activation was also essential for 
mobilization and tissue accumulation of myeloid-derived suppressor cells (MDSCs), a cell 
population mainly known for antiinflammatory properties in cancer. MDSCs were critical 
to regulate innate inflammation, and their adoptive transfer efficiently protected  
gp130-deficient mice from sepsis-associated mortality. The hepatic APPs serum amyloid  
A and Cxcl1/KC cooperatively promoted MDSC mobilization, accumulation, and survival, 
and reversed dysregulated inflammation and restored survival of gp130-deficient mice. 
Thus, gp130-dependent communication between the liver and MDSCs through APPs 
controls inflammatory responses during infection.
© 2010 Sander et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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In the present study we find that gp130–STAT3 signaling 
in hepatocytes and subsequent APP production is required to 
control the inflammatory response by facilitating peripheral 
accumulation and survival of MDSCs in sepsis. We provide 
evidence that MDSCs can directly inhibit inflammatory im-
mune responses and define them as a key autoregulatory com-
ponent of the innate immune system during infection.
RESULTS
Hepatic gp130–STAT3 signaling protects against excessive 
inflammation during sepsis
To better define the role of the hepatic acute-phase res-
ponse during systemic bacterial infections, we used the cecal 
ligation and puncture (CLP) model of polymicrobial sepsis   
(Buras et al., 2005). We had previously generated hepatocyte-
specific  gp130-deficient  mice  (gp130hepa),  which  carry 
loxP sites flanking exon 16 of the gp130 gene and express 
Cre  recombinase  under  control  of  the  albumin  promoter 
(Betz et al., 1998; Streetz et al., 2003). We had further de-
scribed hepatocyte-specific gp130 signaling–deficient mice, 
in which either gp130-induced STAT3 (gp130Stathepa) or 
Ras–MAPK (gp130Rashepa) signaling is impaired (Klein et al., 
2005). The latter express knockin mutations in the intracel-
lular domain of gp130 (Tebbutt et al., 2002) on one allele, 
whereas  the  other  allele  is  floxed  (Klein  et  al.,  2005). 
gp130Rashepa  mice  selectively  lack  wild-type  gp130  in   
hepatocytes expressing only the mutant gp130757F allele in 
which the SHP-2 binding domain is mutated and subsequent 
SHP-2–Ras–extracellular  signal-regulated  kinase  signaling   
is abrogated (Tebbutt et al., 2002; Klein et al., 2005). In 
gp130Stathepa mice, hepatocytes express a mutant gp130 
allele with a truncated intracellular domain, thereby ablating 
STAT3  binding  and  phosphorylation  (Ernst  et  al.,  2001), 
whereas the second allele is deleted by Cre recombination 
(Klein et al., 2005). These mice allowed us to dissect the 
contribution  of  hepatic  gp130–Ras–MAPK  and  gp130–
STAT3 signaling, respectively, during sepsis. gp130hepa and 
gp130Stathepa mice showed impaired induction of acute-
phase response genes and pronounced liver injury after con-
canavalin A–induced hepatitis (Klein et al., 2005). We found 
that hepatic gp130 deficiency severely decreased survival of 
gp130hepa mice during polymicrobial sepsis compared with 
control littermates (Fig. 1 A). Control mice carried loxP sites 
flanking exon 16 of the gp130 gene but did not express Cre 
recombinase (gp130f/f). The protective effects of hepatic 
gp130 signaling required STAT3 activation, demonstrated by 
a markedly decreased survival of gp130Stathepa compared 
with gp130f/f and gp130Rashepa animals (Fig. 1 B). STAT3 
was strongly phosphorylated in the liver after CLP in gp130f/f 
and  gp130Rashepa  mice  but  not  in  gp130hepa  and 
gp130Stathepa mice (Fig. 1 C), demonstrating a strict gp130 
dependency of hepatic STAT3 phosphorylation during in-
fection. Proinflammatory cytokines such as IL-6, TNF, and 
IFN-  are  heavily  involved  in  the  pathogenesis  of  septic 
shock  and  subsequent  organ  failure  (Hotchkiss  and  Karl, 
2003). In our mouse model, serum levels of these cytokines 
Kushner, 1999), their overall role during infections is still 
not well defined.
IL-6 is widely viewed as the major inducer of APP produc-
tion in hepatocytes (Ritchie and Fuller, 1983). However, APP 
production in IL-6–deficient mice is only partly impaired and 
varies depending on the stimulus (Kopf et al., 1994). This 
strongly suggests redundant functions of the IL-6 family cyto-
kines, a large group of cytokines that share the common signal-
ing receptor gp130 (Murakami et al., 1993), or compensatory 
APP induction by other cytokines such as TNF and IL-1. 
Most IL-6 cytokines bind to a membrane-bound cognate re-
ceptor and form a signaling complex with two gp130 recep-
tors. Phosphorylation of distinct tyrosines of the intracellular 
domains of gp130 leads to activation of STAT3 and/or Ras–
mitogen-activated protein kinase (MAPK) signaling. To better 
define the function of the hepatic acute-phase response during 
sepsis and endotoxic shock, we investigated the role of gp130 
and downstream intracellular signaling pathways in hepato-
cytes. Although local effects of hepatic gp130 deficiency have 
been well characterized (Klein et al., 2005), systemic conse-
quences remain unknown.
Innate immune cell activation is critical for host defense 
against invading microorganisms and for the subsequent gen-
eration of an adaptive immune response (Medzhitov, 2007). 
On the other hand, proinflammatory mediators produced by 
innate immune cells are considered key elements in the patho-
genesis of severe sepsis and multiorgan failure (Rittirsch et al., 
2008). Tight control of proinflammatory pathways is therefore 
critical for immune homeostasis and host survival. A complex 
network of activating and regulatory pathways controls innate 
immune responses. In this study, we postulated that the hepatic 
acute-phase response crucially contributes to this regulation. 
Because one of the major proinflammatory mediators in sepsis, 
IL-6, is known to be a strong stimulator of APP production in 
the liver, we hypothesized that the resulting acute-phase re-
sponse potentially acts as a counterregulator of the initial in-
flammatory reaction. We investigated whether hepatic APPs 
affect the central and peripheral immune cell composition, 
which undergoes dramatic changes during infections and   
endotoxemia. Interestingly, a growing body of evidence   
highlights  the  capacity  of  myeloid-derived  suppressor  cells 
(MDSCs), a heterogeneous, immature population of myeloid 
(precursor) cells characterized by the expression of the myeloid 
lineage marker Gr1 and CD11b, to inhibit T cell responses 
(Movahedi et al., 2008; Gabrilovich and Nagaraj, 2009). Al-
though MDSCs are best known and characterized for their 
role in tumor immune evasion and promotion of metastasis 
(Nagaraj et al., 2007; Yang et al., 2008), they have also been 
associated with other pathological conditions like trauma, in-
flammation, and autoimmune disease (Zhu et al., 2007; Haile 
et al., 2008). Moreover, it has been reported that MDSCs ac-
cumulate in the spleens of mice during polymicrobial sepsis 
and suppress T cell functions (Delano et al., 2007). However, 
to which extent MDSCs modify the course of disease or if   
they critically contribute to immune regulation during sepsis 
remains unclear.JEM VOL. 207, July 5, 2010 
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of IL-6 and TNF serum levels several days after the onset of 
sepsis (Byl et al., 1993).
Based on these findings, we explored the possibility of 
defective bacterial clearance in mice lacking hepatic gp130–
STAT3 signaling leading to elevated cytokine levels, because 
we had previously observed that systemic inducible gp130 
deficiency increased bacterial translocation during cholestasis 
peaked similarly at 6 h in all animals (unpublished data). In 
contrast, although the systemic cytokine levels quickly nor-
malized in gp130f/f control and gp130Rashepa mice, they 
remained persistently elevated after 24 and 48 h in gp130hepa 
and gp130Stathepa animals (Fig. 1 D). Interestingly, it has 
been reported that patients with liver cirrhosis have strongly 
elevated sepsis-related mortality and show prolonged elevation 
Figure 1.  gp130–STAT3 signaling in hepatocytes is protective during polymicrobial sepsis and tempers the inflammatory response.  
(A) Decreased survival of gp130hepa mice after CLP (n = 45 per group; pooled data of six independent experiments). (B) Decreased survival of 
gp130Stathepa mice compared with gp130Rashepa mice after CLP (n = 18 per group; pooled data of three independent experiments). (C) Western 
blot for phospho-STAT3 (P-STAT3) in lysates of liver samples taken at the indicated time points. (D) Serum cytokine levels in gp130hepa and 
gp130Stathepa mice compared with controls. IL-6, TNF, and IFN- were measured by ELISA in serum samples collected at the indicated time points 
after CLP (n = 10 per group; pooled data of three independent experiments). (E) Bacterial burdens in the peritoneal cavity (left) and in spleens (right) 
were determined 12 and 36 h after CLP by plating serial dilutions of peritoneal lavage fluid or spleen tissue homogenate on agar plates. CFUs were 
counted after overnight incubation (n = 8–10 per group; pooled data of three independent experiments). (F) Recruitment of immune cells to the peri-
toneal cavity in gp130hepa and control mice. Peritoneal cavities were lavaged 18 h after CLP, and infiltrating cells were counted and analyzed by 
flow cytometry. CD11b+Ly6G+, neutrophils; CD11b+F4/80+, monocytes and macrophages (n = 5 per group; one out of three independent experiments is 
shown). (G) Endotoxic shock was induced by injection of 20 mg/kg LPS and survival was determined (n = 10 per group; pooled data of three indepen-
dent experiments). (H) Serum cytokine concentrations in gp130f/f and gp130hepa mice after LPS treatment were measured by ELISA (n = 8 per 
group; pooled data of three independent experiments). (I) Serum concentrations of aspartate transaminase (AST; left) and alanine transaminase (ALT; 
right; n = 5 per group; one out of three independent experiments is shown). (J) Representative hematoxylin and eosin staining of histological sections 
of liver tissue. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Data are presented as means ± SEM.1456 Acute-phase proteins mobilize MDSCs | Sander et al.
in any of the animals (Fig. S1 B). These data strongly sug-
gested that gp130-dependent signals in the liver facilitated 
mobilization and peripheral accumulation of MDSCs during 
polymicrobial sepsis.
CD11b+Gr1+ MDSCs regulate innate inflammation  
and confer protection during sepsis
Positive CD11b/Gr1 staining is not unique to MDSCs, espe-
cially in compartments with relatively high numbers of my-
eloid cells such as the bone marrow and the peripheral blood. 
The population of CD11b+Gr1+ cells is therefore not equiva-
lent to MDSCs, but it also includes neutrophils and mono-
cytes at various stages of maturation. In the absence of 
exclusive surface markers, MDSCs are best defined function-
ally, through their ability to suppress immune responses. 
Therefore, we analyzed their functions during sepsis and 
sought to investigate a possible link between hepatic gp130 
deficiency, subsequent impairment of MDSC accumulation, 
and reduced survival. We chose two independent approaches 
to test the relevance of MDSCs for host survival. First, we 
depleted Gr1+ MDSCs in control mice using a monoclonal 
antibody directed against Gr1. Depletion of MDSCs signifi-
cantly increased mortality compared with mice treated with a 
control isotype antibody (Fig. 3, A and B). Because anti-Gr1 
treatment is not specific for MDSCs and would also target 
other Gr1+ cells like neutrophils, we decided to adoptively 
transfer MDSCs, isolated from spleens of gp130f/f donors 5 d 
after CLP, into gp130hepa animals. Purified MDSCs from 
spleens of gp130f/f mice showed a characteristic morphologi-
cal heterogeneity and immature phenotype (Fig. 3, C and D). 
Approximately 50% of CD11b+Gr1+ cells expressed Ly6G, a 
neutrophil marker that has been associated with the PMN 
subset of MDSCs (Fig. 3 C). Importantly, MDSCs efficiently 
reversed the detrimental effects of hepatic gp130 deficiency 
during infection (Fig. 3 E). MDSC transfer increased survival 
of gp130hepa mice to wild-type levels (Fig. 3 E) and nor-
malized the serum levels of proinflammatory cytokines in 
gp130hepa mice (Fig. 3 F), thus demonstrating a key role of 
MDSCs in regulating inflammatory responses to infection. 
Previous studies had shown suppressive effects of MDSCs   
on T cells (Delano et al., 2007; Movahedi et al., 2008). We 
found that purified sepsis-induced splenic MDSCs inhibited 
LPS-induced proinflammatory cytokine release while strongly 
inducing the production of IL-10 in primary macrophages 
(Fig. 3, G–I). This skewing effect was dependent on activa-
tion of the MDSCs in vivo. CD11b+Gr1+ cells that were 
sorted from the spleens of untreated mice were impaired in 
their ability to inhibit IL-12 release and to induce IL-10 pro-
duction in LPS-treated macrophages (Fig. 3 H). Preactiva-
tion of CD11b+Gr1+ cells from naive mice with LPS in vitro 
before co-culture with macrophages partially restored IL-10 
induction but failed to recover inhibition of IL-12 produc-
tion (Fig. 3 H). Thus, MDSCs generated during infection show 
a strong antiinflammatory phenotype, in contrast to splenic 
CD11b+Gr1+ cells under steady-state conditions. The anti-
inflammatory functions of MDSCs were largely dependent 
after bile-duct obstruction (Wuestefeld et al., 2003). How-
ever, when we examined bacterial counts of the peritoneal 
cavity and the spleen by plating serial dilutions of peritoneal 
lavage fluid or spleen homogenates 12 h after CLP, we found 
no differences between the groups and nearly all animals had 
cleared the bacteria from the spleens after 36 h (Fig. 1 E). Fur-
thermore, leukocyte recruitment to the peritoneal cavity was 
equal in all groups (Fig. 1 F), indicating that the innate im-
mune response was intact. This suggested that impaired coun-
terregulation of the initial inflammatory response rather than 
defective antibacterial defense was responsible for the exacer-
bated inflammation and increased mortality of gp130hepa 
mice. To further validate this hypothesis, we induced sterile 
endotoxic shock by injection of LPS. Similar to the infection 
model, hepatic gp130 deficiency strongly increased mortality 
(Fig. 1 G) and caused prolonged inflammation (Fig. 1 H). We 
also evaluated the liver-intrinsic effects of gp130 deficiency 
during sepsis and found that gp130hepa mice showed mark-
edly elevated liver enzyme serum levels (Fig. 1 I) and pro-
nounced hepatocyte necrosis (Fig. 1 J) compared with gp130f/f 
mice after CLP. Enhanced liver injury not only reflected the 
severity of the systemic inflammation but also confirmed the 
autoprotective function of IL-6–gp130 signaling in hepato-
cytes. Collectively, these experiments suggested that liver- 
derived gp130-dependent factors were essential to control the 
inflammatory response to infection.
Hepatic gp130 signaling is required for mobilization  
and accumulation of MDSCs
We  next  asked  whether  dysregulated  inflammation  in 
gp130hepa mice was associated with changes in the compo-
sition of immune cells in the peripheral blood, lymphoid   
organs, and the liver. We especially focused on MDSCs, an 
immature population of myeloid (precursor) cells character-
ized by surface expression of CD11b and Gr1. MDSCs have 
recently gained significant attention for their role in malig-
nancies. Interestingly, one previous study reported expansion 
of MDSCs in the bone marrow and accumulation in the 
spleens of septic mice (Delano et al., 2007). We therefore 
monitored the expansion of CD11b+Gr1+ cells in the bone 
marrow, as well as their mobilization to the peripheral blood 
and accumulation in the spleens, lymph nodes, and livers of 
mice at various time points after induction of polymicrobial 
sepsis. We found that although CD11b+Gr1+ cells expanded 
similarly in the bone marrow of all mice, the population of 
circulating CD11b+Gr1+ cells in the blood was significantly 
reduced in gp130hepa mice (Fig. 2, A and B). We observed 
the accumulation of MDSCs in the spleens of septic gp130f/f 
control mice, as previously reported (Fig. 2, A–C; Delano   
et al., 2007). However, splenic enrichment of MDSCs after 
CLP was completely blocked in gp130hepa animals, as dem-
onstrated by flow cytometry and immunofluorescence micros-
copy (Fig. 2, A–C). Hepatic accumulation of CD11b+Gr1+ cells 
was also significantly decreased in gp130hepa mice (Fig. S1 A). 
In agreement with a previous study (Delano et al., 2007), no 
increase of MDSCs in mesenteric lymph nodes was observed JEM VOL. 207, July 5, 2010 
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proteins, we noticed three groups of genes with   
a  particularly  strong  gp130-dependent  induction:   
(1) classical APPs such as 2-macroglobulin or SAA; 
(2) chemokines with chemotactic activity on myeloid 
cells, such as Cxcl1 (KC), Cxcl2, or Ccl3 (MIP-1); 
and (3) antiinflammatory cytokines such as IL-1R an-
tagonist (IL-1Ra; Fig. 4 A and Fig. S2). These results 
were  further  confirmed  by  real-time  RT-PCR   
(Fig. 4 B). Accordingly, the serum levels of SAA and 
KC were strongly elevated in gp130f/f but not in 
gp130hepa mice 24 h after CLP, showing that he-
patic gp130 signaling controls the systemic levels of 
these proteins (Fig. 4 C). Transcript levels of IL-6 
were also significantly reduced in gp130hepa mice 
compared with controls (8.3- vs. 1.9-fold induction; 
unpublished data), which is noteworthy because it   
is widely believed that the liver is a major source of   
IL-6 and TNF during sepsis (Matuschak, 1996). In 
contrast,  we  found  that  gp130hepa  mice  showed   
elevated serum levels of IL-6 after CLP despite re-
duced hepatic IL-6 production (Fig. 1 D). Hepatic TNF 
transcription  was  not  differentially  regulated  by  gp130   
(unpublished data). This suggests a mainly extrahepatic pro-
duction during sepsis, e.g., in macrophages activated by micro-
bial products.
Having identified hepatic genes regulated by gp130 during 
polymicrobial infection, we aimed to determine their func-
tional contributions to the regulation of the inflammatory re-
sponse and MDSC accumulation. To this end, we treated 
gp130hepa mice that failed to induce SAA, KC, and IL-1Ra 
with the respective recombinant proteins. Administration of 
SAA or KC alone partly restored survival (Fig. 5, A and B), 
whereas a combination of both proteins completely rescued 
gp130hepa mice, normalizing survival rates and systemic cyto-
kine levels (Fig. 5, A, B, D, and E). In sharp contrast, treatment 
with the antiinflammatory cytokine IL-1Ra (anakinra) resulted 
in 100% mortality of gp130hepa mice after 4 d (Fig. 5 C). 
Detrimental effects of IL-1Ra treatment may be caused by 
impaired bacterial clearance or defective tissue repair in the 
absence of IL-1R signaling.
on direct cell–cell contact. Separation of MDSCs and macro-
phages in a Transwell system strongly reduced IL-10 induction 
but only partially blocked IL-12 suppression (Fig. 3 I), indi-
cating that additional soluble factors such as TGF- may 
play a role as well. Our results suggest that direct interac-
tion of MDSCs with innate effector cells may constitute a 
novel autoregulatory mechanism of innate immune responses 
to infection.
Liver-derived serum amyloid A (SAA) and KC control 
inflammation and promote MDSC mobilization  
and accumulation
Next we aimed to identify liver-derived gp130-dependent 
factors that were involved in mobilization and peripheral ac-
cumulation  of  MDSCs,  thereby  controlling  inflammation. 
Transcriptional analysis of 16,475 genes by gene microarray in 
liver tissue samples taken from untreated and septic gp130f/f 
and gp130hepa mice revealed a total of 3,936 genes that 
were regulated >1.5-fold 12 h after CLP, 2,266 of which 
were differentially regulated by gp130. Focusing on secreted 
Figure 2.  Mobilization and splenic accumulation of 
CD11b+Gr1+ MDSCs are impaired in gp130hepa mice.  
(A) Representative flow cytometric analysis and (B) graphic 
analysis of CD11b+Gr1+ cell frequencies in bone marrow,  
peripheral blood, and spleens in gp130f/f and gp130hepa 
mice at the indicated time points after CLP (n = 5–12 per  
time point per group; pooled data of 12 independent  
experiments). #, gp130f/f did not survive to 7 and 10 d in  
sufficient numbers and could therefore not be included in  
the analysis. (C) Immunofluorescence staining of spleen  
sections for CD11b (red, CD11b; blue, DAPI) to show infiltration 
of myeloid cells after induction of sepsis. Spleens were  
explanted at the indicated time points. Bars, 100 µm.  
***, P < 0.001. Data are presented as means ± SEM. n.d.,  
not determined.1458 Acute-phase proteins mobilize MDSCs | Sander et al.
1994; Cheng et al., 2008a), and has also been implicated in the 
pathogenesis of chronic inflammation such as atherosclerosis 
(Luchtefeld et al., 2007). SAA treatment of gp130hepa mice 
during sepsis efficiently reduced mortality (Fig. 5, B and D) 
and inflammation (Fig. 5 E), but importantly, it nearly re-
stored MDSC numbers in the spleen, especially when given 
in combination with KC (Fig. 6 B), demonstrating that SAA 
was sufficient to rescue gp130hepa mice during sepsis. How-
ever, it was not clear if SAA was required in the context of an 
intact acute-phase response. Blocking SAA activity in gp130f/f 
mice by injection of neutralizing anti-SAA antibodies strongly 
enhanced sepsis-related mortality and systemic cytokine levels 
(Fig. 5, F and G). Given the large quantities and vast variety 
Notably, administration of recombinant KC, known as a 
potent chemoattractant for polymorphonuclear cells (Bozic   
et al., 1995), significantly elevated the number of circulating 
CD11b+Gr1+ cells in septic gp130hepa mice (Fig. 6 A). Re-
combinant KC also induced chemotaxis of purified MDSCs 
in vitro (Fig. S3). In contrast, splenic MDSC numbers were 
only marginally elevated in KC-treated gp130hepa animals 
(Fig. 6 B). Thus, it was conceivable that KC was involved in 
mobilization of myeloid cells from the bone marrow, whereas 
accumulation of MDSCs in the spleen required additional fac-
tors. We therefore tested the ability of SAA to restore splenic 
MDSCs. SAA is mostly regarded as a proinflammatory protein 
with activating properties on innate immune cells (Badolato et al., 
Figure 3.  MDSCs regulate inflammatory responses and confer protection during sepsis. (A and B) gp130f/f mice were injected with monoclonal 
antibodies against Gr1 (RB6-8C5) 24 h before and after CLP. Efficient depletion of Gr1+ MDSCs was determined by flow cytometry of total splenocytes 
(A). Survival was monitored (B; n = 9 per group; pooled data of three independent experiments). (C) gp130f/f donor mice underwent CLP and 5 d later 
MDSCs were isolated from the spleens. CD11b+Gr1+ purity of >90% was confirmed by flow cytometry (top right). Further analysis of Ly6G expression of 
MDSCs (bottom right). (D) Cytospins of MDSCs. Bars, 10 µm. (E) gp130hepa mice received either 5 × 106 MDSCs or saline 1 and 24 h after CLP and sur-
vival was determined (n = 12 per group; pooled data of three independent experiments). (F) Serum samples were taken at the indicated time points and 
analyzed for IL-6 and IFN- by ELISA. (G) Peritoneal macrophages (M) were co-cultured with MDSCs isolated from septic gp130f/f mice at a ratio of  
1:3 and were stimulated with LPS at the indicated concentrations. Cytokine release was determined by ELISA (one out of five independent experiments 
shown). (H) Gr1+CD11b+ cells were isolated from the spleens of septic mice (MDSC) or naive mice (MDSC()) and co-cultured with macrophages and 
stimulated with LPS. Some cells from naive mice were pretreated with 100 ng/ml LPS in vitro before co-culture with macrophages (MDSC(/LPS)).  
(I) MDSCs and macrophages were separated in a Transwell and stimulated with LPS. Cytokine release was determined by ELISA (H and I; one out of three 
independent experiments shown). *, P < 0.05; ***, P < 0.001. Data are presented as means ± SEM.JEM VOL. 207, July 5, 2010 
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gp130hepa hepatocytes fully restored the antiapoptotic capac-
ity (Fig. 6 D), demonstrating that liver-derived SAA, produced 
in response to gp130 activation, protects MDSCs from apop-
tosis. Therefore, SAA inhibits MDSC apoptosis in vitro and   
in vivo. Collectively, these results define a pivotal role of liver-
derived proteins in regulating MDSC mobilization and sur-
vival in sepsis, and the production of these factors requires 
gp130–STAT3 signaling in hepatocytes.
DISCUSSION
Although the use of antibiotics dramatically decreased the 
mortality of bacterial infections in the last century, sepsis- 
related mortality has remained high, even with appropriate 
antibiotic therapy, fluid replacement, and organ function 
support (Angus et al., 2001; Hotchkiss and Karl, 2003). Thus, 
there is an urgent need for targeted sepsis therapies. Various 
approaches to inhibit major inflammatory mediators such as 
TNF, IL-1, leukotrienes, or the endotoxin component lipid 
A have been tested in clinical trials with largely discouraging 
results (Fisher et al., 1996; Parrish et al., 2008). In contrast, 
exploiting endogenous regulatory mechanisms may represent 
a more promising strategy (Parrish et al., 2008). In fact, the 
only  sepsis  treatment  approved  by  the  Food  and  Drug   
Administration in the United States is administration of acti-
vated protein C (Bernard et al., 2001), a plasma protein with 
of APPs produced during sepsis, we were surprised to find 
that inhibition of SAA alone had such dramatic effects, and   
it indicates a central role for this APP in the regulation   
of the inflammatory response to infection. Thus, hepatic 
APPs promote MDSC accumulation and regulate inflam-
mation during sepsis.
Contraction of immune cells, particularly lymphocytes, by 
apoptosis during severe infections is a well-known phenome-
non (Hotchkiss and Nicholson, 2006). We found a higher   
percentage of annexin V+ apoptotic MDSCs in spleens of 
gp130hepa mice compared with gp130f/f mice (Fig. 6 C). In-
terestingly,  the  apoptotic  fraction  was  significantly  reduced   
in SAA-treated gp130hepa animals (Fig. 6 A). Thus, we rea-
soned that SAA promotes survival of peripheral MDSCs espe-
cially in light of a recent report suggesting an antiapoptotic 
function of SAA in neutrophils (Christenson et al., 2008). We 
therefore tested the potential of SAA to inhibit apoptosis of 
MDSCs isolated from spleens of septic mice. Indeed, we found 
that  both  recombinant  SAA  and  supernatant  of  stimulated   
primary  hepatocytes  isolated  from  gp130f/f  but  not  from 
gp130hepa mice prevented TNF-induced MDSC apoptosis 
(Fig. 6 D). Primary hepatocytes isolated from control gp130f/f 
and gp130hepa mice were stimulated with leukemia inhibitory 
factor, a strong gp130 agonist, to induce production of gp130-
dependent proteins. Addition of SAA to the supernatant of 
Figure 4.  Hepatocytes launch a specific gp130-dependent transcriptional program in response to infection. (A) Gene microarray analysis of 
liver tissue before and 12 h after onset of polymicrobial sepsis (n = 3 per group). Genes with >1.5-fold change after CLP in three out of three samples 
were clustered in a heat map diagram. Red indicates up-regulation compared with control mice, and green indicates down-regulation; all genes with an 
absolute fold change <1.5 and/or a p-value >0.05 are shown as black (no change). (B) Quantitative real-time PCR of liver samples taken from untreated 
gp130f/f and gp130hepa mice and 12 h after induction of sepsis (n = 8 per group; pooled data of three independent experiments). APPs (2-macro-
globulin and SAA), chemokines (KC and Cxcl2), and antiinflammatory cytokines (IL-1Ra) were analyzed. (C) Serum protein levels of SAA (top) and KC (bot-
tom) were analyzed by ELISA in gp130f/f and gp130hepa mice 24 h after CLP (n = 7 per group; three independent experiments). *, P < 0.05; **, P < 0.01; 
***, P < 0.001. Data are presented as means ± SEM.1460 Acute-phase proteins mobilize MDSCs | Sander et al.
inhibit proinflammatory cytokine release. Thus, they repre-
sent an autoregulatory component of the innate immune   
system, contributing to carefully balance the inflammatory   
response to bacterial infection and sepsis.
Knowledge  about  factors  and  conditions  that  induce 
MDSC production and function as well as their homing to 
peripheral tissues or lymphoid organs is incomplete. Obser-
vations made in mouse cancer models have suggested that   
tumor-derived factors induce the expansion of MDSCs and 
inhibit their differentiation into dendritic cells by activation 
of  JAK2–STAT3  pathways  in  MDSCs  (Nefedova  et  al., 
2004). In our model, JAK2–STAT3 signaling in hematopoi-
etic cells was intact and we thus observed no differences in 
MDSC expansion in the bone marrow. Instead, hepatocyte-
specific deletion of gp130–STAT3 signaling abrogated the 
peripheral accumulation of MDSCs. We found that gp130-
dependent production of SAA and KC in the liver coopera-
tively facilitated MDSC mobilization and survival. However, 
how MDSCs home to the spleen and not to other lymphoid 
organs like the mesenteric lymph node is not clear at this 
point.  A  previous  study  reported  that  STAT3-inducible   
myeloid-related protein S100A9 induced MDSC production 
in cancer, leading to inhibition of antitumor responses (Cheng 
et al., 2008b). Interestingly, we found a 39-fold increase in 
S100A9 gene expression in livers of gp130f/f mice versus an 
8-fold  induction  in  gp130hepa  mice  (unpublished  data), 
suggesting that the liver might be a potent source of MDSC-
inducing proteins not only during infections but potentially 
also in cancer. In this respect, it is also noteworthy that MDSCs 
have  been  shown  to  accumulate  in  human  hepatocellular   
anticoagulant  and  antiinflammatory  functions.  Its  proform 
protein C is produced in the liver. In the current study, we 
found that hepatic APPs, namely SAA and KC, were protec-
tive during sepsis and promoted the function of MDSCs. 
MDSCs were capable of controlling inflammatory responses 
and reducing mortality in a mouse model of polymicrobial 
sepsis. Myeloid cells with antiinflammatory functions have 
been  recognized  in  tumor-bearing  mice  for  a  long  time 
(Young et al., 1987), but their functional significance for   
tumor immune evasion, angiogenesis, and metastasis has only 
recently gained broader attention (Nagaraj et al., 2007; Yang 
et al., 2008). MDSCs have also been implicated in other 
pathological conditions such as autoimmunity (Zhu et al., 
2007; Haile et al., 2008). However, despite significant ad-
vances in cancer, there is only limited data on MDSC func-
tions  in  infections  and  sepsis.  Expansion  of  MDSCs  with   
T cell–suppressive properties during sepsis in mice has been 
reported (Delano et al., 2007), but unlike for many cancers, 
their contribution to disease progression and host survival 
during infections remained undefined. In this paper, we dem-
onstrate that MDSCs display host-protective antiinflamma-
tory functions during polymicrobial infection. gp130hepa 
animals that failed to accumulate MDSCs in the spleen suf-
fered from dysregulated inflammation and increased mor-
tality, whereas adoptive transfer of splenic MDSCs into 
gp130hepa  mice  conferred  protection.  It  is  known  that 
adaptive immune cells are required to control innate immune 
responses to infections (Kim et al., 2007). As shown in this 
study and previously with cancer-derived MDSCs (Sinha et al., 
2007), MDSCs can directly interact with macrophages and 
Figure 5.  Recombinant SAA and KC are protective during sepsis. (A–D) Survival of gp130f/f mice compared with gp130hepa mice treated 
with SAA (A), KC (B), IL-1Ra (anakinra; C) or SAA and KC (D) in combination or equal volumes of NaCl 1 and 24 h after CLP (n = 9 per group; pooled 
data of three independent experiments). (E) Serum concentrations of IL-6 (left) and IFN- (right) at the indicated time points measured by ELISA.  
(F) Survival of gp130f/f mice treated with neutralizing anti-SAA antibodies or inactive control isotype IgG. (G) IFN- serum concentrations at the  
indicated time points after CLP in gp130f/f mice treated with anti-SAA or control antibodies (n = 6 per group; pooled data of two independent  
experiments). *, P < 0.05. Data are presented as means ± SEM.JEM VOL. 207, July 5, 2010 
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MyD88-dependent production of cytokines such as IL-6 are 
responsible for these effects. Our present study does not 
directly address this issue, but the results demonstrate that 
MyD88–NF-B–dependent IL-6 cytokines and subsequent 
gp130 signaling in hepatocytes are crucial elements for pe-
ripheral accumulation of MDSCs during sepsis. This concept 
is  intriguing  because  it  would  implicate  a  novel  negative 
feedback mechanism of Toll-like receptor (TLR)–mediated 
inflammatory responses. We found that among all APPs, SAA 
played a pivotal role in regulating inflammatory responses 
and survival. Interestingly, SAA was recently identified as   
an  endogenous  TLR2  ligand  activating  MyD88  signaling 
(Cheng et al., 2008a). It is therefore conceivable that SAA 
activates TLR2–MyD88 in MDSCs to protect them from 
apoptosis. This explanation would also support the previously 
reported requirement for MyD88 for MDSC expansion dur-
ing sepsis (Delano et al., 2007).
Our present study demonstrates that MDSCs have potent 
host-protective antiinflammatory functions during polymicro-
bial infection, and our results directly link MDSC functions 
during infection to hepatic APPs induced by gp130–STAT3 
activation. We show that APPs are crucial regulators of inflam-
matory responses to infection, highlighting the close relation-
ship between hepatocytes and innate immune cells, and SAA 
plays a key role in this regulatory process. In conclusion, the 
present study adds important information to our current under-
standing of the role of the liver and hepatic APPs in regulating 
inflammatory responses and maintaining immune homeostasis 
during infection.
MATERIALS AND METHODS
Mice. We used 8–12-wk-old male gp130f/f, gp130hepa, gp130Stathepa, 
and gp130Rashepa mice, as described previously (gp130 mutant mice were 
provided  by  M.  Ernst,  Ludwig  Institute  for  Cancer  Research,  Victoria,   
Australia; Klein et al., 2005). All experiments were approved by the Institu-
tional Animal Care and Use Committee of the RWTH University Hospital. 
All experiments were performed in agreement with the Guide for the Care 
and Use of Laboratory Animals (National Institutes of Health publication   
no. 86-23, revised 1985).
CLP. We induced polymicrobial sepsis by CLP (Rittirsch et al., 2009). In 
brief, mice were anesthetized, and the cecum was ligated and punctured twice 
with a 20-gauge needle. We monitored mice every 6 h for 24 h and then every 
12 h until the end of the experiment (between 5 and 10 d).
LPS-induced endotoxic shock. Mice received 20 mg/kg LPS i.p. and were 
monitored every 6 h for 24 h and then every 12 h until the end of the experi-
ment (between 3 and 5 d).
Cell isolation and culture. We isolated MDSCs from spleens of gp130f/f 
mice 5 d after CLP. After sacrifice, spleens were explanted and splenocytes were 
isolated by collagenase digestion. Red blood cells were lysed using lysing buf-
fer (Pharmlyse; BD). MDSCs were purified from cell suspensions by mag-
netic cell sorting (MACS; Miltenyi Biotec) using anti-CD11b–conjugated 
magnetic beads (Miltenyi Biotec). Purity was determined by flow cytometry. 
We used only cell preparations with a purity >90% for further experiments. 
Alternatively, mice were injected with 5 mg/kg LPS i.p., and 5 d later 
CD11b+Gr1+ splenocytes were purified by FACS sorting (Influx; BD). For 
overnight culture experiments, cells were kept in RPMI 1640 (Invitrogen) 
supplemented with 10% heat-inactivated FCS (Sigma-Aldrich). MDSCs were 
carcinoma, a cancer known to notoriously escape antitumor 
immune responses (Hoechst et al., 2008). Moreover, a recent 
study demonstrates frequent gain-of-function mutations in 
the gp130 gene in liver tumors (Rebouissou et al., 2009). 
Future investigations should therefore determine the role of 
gp130–STAT3 activation in the liver for MDSC regulation 
in different pathological conditions including cancer. Because 
MDSCs represent a heterogeneous population, it is conceiv-
able that phenotype and function as well as activating factors 
differ between the various conditions in which they are 
found. Although the role of JAK2–STAT3 for MDSC in-
duction has been studied mainly in malignancies, it was   
previously shown that the expansion of MDSCs during   
polymicrobial  sepsis  required  MyD88  signaling  (Delano   
et al., 2007). However, it is not clear if direct MyD88 activa-
tion in MDSCs or, alternatively, indirect mechanisms like 
Figure 6.  Hepatocyte-derived SAA reconstitutes splenic MDSCs 
and protects them from apoptosis. (A) Representative flow cytometric 
analysis of white blood cells from gp130f/f and gp130hepa mice treated 
with NaCl or KC 5 d after CLP. (B) MDSCs measured in spleens from 
gp130hepa mice treated with the indicated compounds 5 d after CLP. 
The percentage of CD11b+Gr1+ cells is indicated. (C) Annexin V staining of 
CD11b+Gr1+ cells indicating the fraction of apoptotic MDSCs in the 
spleen. (D) In vitro apoptosis of MDSCs induced by TNF can be inhibited 
by SAA or supernatants from primary hepatocytes isolated from gp130f/f 
(gp130f/f HSN) but not from gp130hepa (gp130hepa HSN) mice.  
Hepatocytes were stimulated with the potent gp130 ligand leukemia  
inhibitory factor for 6 h. Apoptosis of MDSCs was determined by measur-
ing caspase-3 activity (one out of three independent experiments is 
shown). Data are presented as means ± SEM.1462 Acute-phase proteins mobilize MDSCs | Sander et al.
samples from three mice per experimental group were used for microarray 
analysis. RNA samples were prepared and hybridized on GeneChip Mouse 
Genome 430 2.0 arrays (Affymetrix). Gene expression levels were calculated 
applying the GeneChip content-corrected robust multichip average algorithm 
and a remapped GeneChip description file. Differentially expressed genes 
were identified using Limma statistics. Genes with a corrected p-value similar 
or <0.05 and/or fold change >1.5 or less than 1.5 were considered signifi-
cantly regulated. Ingenuity Pathway Analysis (version 5.5; Ingenuity Systems) 
and ErmineJ Gene Score Resampling were used to identify the most signifi-
cantly changed canonical signaling pathways or gene ontology biological pro-
cesses in gp130f/f and gp130hepa mice 12 h after sepsis onset, using a p-value 
similar to or <0.05 as input criteria. Fold changes of selected genes were visual-
ized in a heat map diagram. Microarray data have been deposited in the Gene 
Expression Omnibus under accession no. GSE22009.
Real-time PCR analysis was performed to confirm data from the gene 
array. RNA was isolated using RNeasy columns (QIAGEN) according to 
the manufacturer’s instructions. First-strand synthesis was performed with 
Oligo dT primers and reverse transcription was performed with reverse tran-
scriptase (M-MLV; Invitrogen). Quantitative real-time PCR was performed 
using SYBR Green reagent (Invitrogen) in a real-time PCR system (Prism 
7300;  Applied  Bioscience).  Reactions  were  performed  in  duplicate  and 
GAPDH values were used to normalize gene expression.
Histology. Mice were sacrificed at the time points indicated in the figures. 
5-µm  cryosections  of  spleens  were  stained  with  rat  anti–mouse  CD11b 
monoclonal antibody and DAPI (both from BD).
Western blot analysis. Protein extracts were separated on a 10% SDS–
polyacrylamide gel and transferred to nitrocellulose membranes (Whatman). 
Membranes were blocked with 5% milk in PBS and probed with phospho-
STAT3 (Cell Signaling Technology) and GAPDH (Biogenesis) antibodies.
Determination of bacterial burden. Mice were sacrificed 24 h after 
CLP. The peritoneal cavity was lavaged and the lavage fluid was plated on 
blood and MacConkey agar plates in serial dilutions. Spleens were removed, 
homogenized, and plated in serial dilutions on agar plates. CFUs were 
counted after overnight incubation.
Determination of apoptosis by caspase-3 kinase activity. Purified 
MDSCs were cultured overnight with the indicated compounds. Cells 
were washed and lysed at 4°C in 5 mmol/liter Tris/HCl, pH 8, 20 µmol 
ethylenediaminetetraacetic acid, 0.5% Triton X-100. Lysates were clari-
fied by centrifugation at 13,000 g for 10 min. The reaction mixture con-
tained 30 µg of cellular lysates,1,000 µl of assay buffer (20 mmol/liter 
Hepes, pH 7.5, 10% glycerol, 2 mM dithiothreitol), and 20 mM caspase-3 
substrate (Ac-DEVD-AMC; BD). After 2 h of incubation in the dark,   
enzymatic activity was measured in a luminescence spectrophotometer 
(LS-50; PerkinElmer).
Determination of apoptosis by annexin V staining. Cells were stained 
for CD45, Gr1, and CD11b, followed by incubation with annexin V–FITC 
(BD), and were analyzed by flow cytometry.
Statistical analysis. Statistical significance was determined by an unpaired 
two-tailed Student’s t test implemented in Excel (version 11.0; Microsoft), 
or when appropriate (Fig. 1, D, H, and I; Fig. 2 B; Fig. 3 F; and Fig. 5, E and G) 
by a two-way ANOVA grouped test with subsequent Bonferroni posttest 
correction using Prism 5 software (GraphPad Software, Inc.).
Online supplemental material. Fig. S1 shows the accumulation of 
CD11b+Gr1+ MDSCs in liver and mesenteric lymph nodes after CLP. Fig. S2 
shows a heat map with the complete list of genes shown in Fig. 4 A. Fig. S3 
shows KC-induced chemotaxis of CD11b+Gr1+ cells isolated from spleen 
and bone marrow. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20091474/DC1.
cultured with the following substances: mouse TNF (PeproTech), LPS 
(Sigma-Aldrich), and SAA (PeproTech).
For generation of peritoneal macrophages, we injected mice with 1 ml 
thioglycollate (BD) i.p. Total cells were harvested after 72 h and plated at 
106 cells/ml in RPMI 1640 supplemented with 10% FCS and 1% penicillin/ 
streptomycin (Invitrogen). After overnight culture, nonadherent cells were 
removed and purity of macrophages was confirmed by F4/80 staining and 
flow cytometry.
Primary hepatocytes were isolated from gp130f/f and gp130hepa mice 
by collagenase perfusion as described previously (Klein et al., 2005). 106 cells 
were cultured on 6-cm culture plates with DMEM (Invitrogen) containing 
4.5 g/liter glucose, 10% FCS, and penicillin/streptomycin overnight. Cells 
were stimulated with 50 ng/ml leukemia inhibitory factor (PeproTech) for 
6 h, and supernatants were harvested and stored at 80°C.
In vitro culture of MDSCs. Culture conditions have been used previ-
ously (Delano et al., 2007). After MACS purification of splenic MDSCs 
from control gp130f/f mice 5 d after CLP, cells were plated at 106 cells/ml 
in RPMI 1640 supplemented with 10% FCS, 2 mM l-glutamine, 200 U/ml 
penicillin,  and  50  µg/ml  streptomycin  and  cultured  overnight  with  the 
compounds indicated in the figures. For in vitro suppression assays, purified 
MDSCs were co-cultured with peritoneal or bone marrow–derived macro-
phages and stimulated with LPS, and subsequent cytokine release was mea-
sured by ELISA. In some cases, MDSCs were separated from macrophages 
in Transwells (pore size = 0.4 µm; Corning) For in vitro migration studies, 
splenic or bone marrow–derived CD11b+Gr1+ cells were seeded in Tran-
swells (pore size = 3 µm; Corning), and increasing amounts of recombinant 
KC (PeproTech) were added to the lower well. After 3 h, migrated cells 
were counted in a hemocytometer and the migration index of migrated/
nonmigrated cells was calculated.
Adoptive MDSC transfer. MDSCs were isolated as described in Cell iso-
lation and culture, and gp130hepa mice received 5 × 106 MDSCs i.v. 1 and 
24 h after CLP. Control mice were treated with equal volumes of NaCl.
Depletion of Gr1+ cells. We generated monoclonal antibodies against Gr1 
from RB6-8C5 hybridoma cells, and gp130f/f mice received 10 mg/kg of 
antibodies 24 h before and 24 h after CLP. Efficiency of depletion was moni-
tored by FACS. Control mice received nonspecific isotype IgG antibodies.
Treatment of animals with recombinant SAA, KC, and IL-1Ra. 
Mice received 0.8 mg/kg recombinant SAA or 40 µg/kg KC or a combina-
tion of both i.v. 1 and 24 h after CLP. Control mice received the same volume 
of saline. IL-1Ra (anakinra; Kineret; Amgen) was injected subcutaneously 
every 4 h over a period of 24 h.
Systemic neutralization of SAA. Mice received 50 mg/kg of a combina-
tion  of  anti-SAA  monoclonal  antibodies  (mc29  and  mc4;  1:1)  directed 
against the highly conserved (invariant) region of SAA i.p. 12 h before and 
33 mg/kg 12 h after CLP. Control mice received equivalent amounts of in-
active control antibodies (mc1).
Cytokine measurements. Serum samples were collected by bleeding at 
the time points indicated in the figures. IL-6, TNF, IFN-, and KC were 
measured by ELISA (R&D Systems). SAA was measured by ELISA (Invitro-
gen). IL-6, TNF, IL-12, and IL-10 were measured from cell-culture super-
natants by ELISA (R&D Systems).
Flow  cytometry.  Cell  suspensions  were  incubated  with  the  following   
fluorochrome-conjugated antibodies and analyzed with a FACSCanto II 
(BD): CD45, Gr1 (both from BD), and CD11b (eBioscience).
Gene microarray analysis and real-time PCR. gp130f/f and gp130hepa 
mice were sacrificed without previous treatment or 12 h after CLP. Livers 
were  explanted  and  tissue  samples  were  frozen  immediately.  Liver  RNA   JEM VOL. 207, July 5, 2010 
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